SCHEMBL5389191

SCHEMBL5389191

CSc1nsc(OCc2ccc([N+](=O)[O-])cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPC1 O15118 2/20 0.43
IDO1 P14902 2/20 0.43
MAPT P10636 2/20 0.43
MAOB P27338 2/20 0.43
RAB9A P51151 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
KDR P35968 1/20 0.41
MAOA P21397 1/20 0.40
TLR3 O15455 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5381819 0.85 KMT2A (0.52) LMNAPOLBGAAL3MBTL1MEN1
SCHEMBL5381872 0.80 L3MBTL1 (0.56) LMNAL3MBTL1MEN1KMT2AIDO1
SCHEMBL5375690 0.79 RAB9A (0.45) LMNAPOLBL3MBTL1MEN1KMT2A
SCHEMBL5373469 0.76 MAOB (0.41) POLBL3MBTL1MEN1KMT2ANPC1
SCHEMBL5377692 0.74 MAPK1 (0.39) L3MBTL1MEN1KMT2A
SCHEMBL5389354 0.71 MAPK1 (0.43) LMNAPOLBL3MBTL1MEN1KMT2A
SCHEMBL11566189 0.70 MAOB (0.63) LMNAMEN1KMT2ANPC1IDO1
SCHEMBL13381992 0.68 MEN1 (0.37) LMNAL3MBTL1MEN1KMT2AMAPT
SCHEMBL18459148 0.68 IDO1 (0.59) LMNAPOLBL3MBTL1IDO1MAPT
SCHEMBL4799608 0.68 SMN1; SMN2 (0.42) LMNAGAAL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-20050215578-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-09-29 US disclosed
EP-1475374-A1 THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215578-A1 Thiadiazole compounds and use thereof C5, C3AR1, TH LMNA 3208/4885POLB 4393/4885GAA 4793/4885
US-20070293510-A1 Thiadiazole compounds and use thereof C5, C3AR1, TH LMNA 3325/4885POLB 4378/4885GAA 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.